Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abcam plc stock logo
ABCZF
Abcam
C$22.25
C$22.25
C$5.00
C$23.80
N/AN/A2,659 shsN/A
AMHCU
Amplitude Healthcare Acquisition
$16.28
+7.8%
$16.28
$9.51
$16.28
N/AN/A4,175 shs4,300 shs
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
$0.00
N/AN/A11,650 shsN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
$0.00
$0.00
$0.07
N/AN/A1.28 million shsN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abcam plc stock logo
ABCZF
Abcam
0.00%0.00%0.00%0.00%0.00%
AMHCU
Amplitude Healthcare Acquisition
0.00%0.00%0.00%0.00%0.00%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00%0.00%0.00%0.00%-85.71%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abcam plc stock logo
ABCZF
Abcam
C$22.25
C$22.25
C$5.00
C$23.80
N/AN/A2,659 shsN/A
AMHCU
Amplitude Healthcare Acquisition
$16.28
+7.8%
$16.28
$9.51
$16.28
N/AN/A4,175 shs4,300 shs
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
$0.00
N/AN/A11,650 shsN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
$0.00
$0.00
$0.07
N/AN/A1.28 million shsN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abcam plc stock logo
ABCZF
Abcam
0.00%0.00%0.00%0.00%0.00%
AMHCU
Amplitude Healthcare Acquisition
0.00%0.00%0.00%0.00%0.00%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00%0.00%0.00%0.00%-85.71%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abcam plc stock logo
ABCZF
Abcam
0.00
N/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
0.00
N/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00
N/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abcam plc stock logo
ABCZF
Abcam
N/AN/AN/AN/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
N/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abcam plc stock logo
ABCZF
Abcam
N/AC$0.17130.73N/AN/AN/AN/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A-$0.16N/AN/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abcam plc stock logo
ABCZF
Abcam
C$0.070.32%N/A42.48%N/A
AMHCU
Amplitude Healthcare Acquisition
N/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Abcam plc stock logo
ABCZF
Abcam
43.58%
AMHCU
Amplitude Healthcare Acquisition
N/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
32.45%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Abcam plc stock logo
ABCZF
Abcam
1,750N/AN/ANot Optionable
AMHCU
Amplitude Healthcare Acquisition
20N/AN/ANot Optionable
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/ANot Optionable
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
460N/AN/ANot Optionable

Recent News About These Companies

CSE Bulletin: Delist - 4Front Ventures Corp. (FFNT)
4Front Ventures declares bankruptcy
4Front Ventures Files for Bankruptcy Protection
4Front Ventures shifts to OTC Pink Market
Marijuana operator 4Front files for receivership
4Front Provides Update on MCTO Application
4Front Ventures delays annual filings, can’t pay auditors

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abcam stock logo

Abcam OTCMKTS:ABCZF

C$22.25 0.00 (0.00%)
As of 05/22/2026

Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.

Amplitude Healthcare Acquisition OTCMKTS:AMHCU

$16.28 +1.18 (+7.81%)
As of 09/24/2021

Amplitude Healthcare Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to focus on the life sciences and pharmaceutical services sectors in the United States and Europe. Amplitude Healthcare Acquisition Corporation was incorporated in 2019 and is based in New York, New York.

Abattis Bioceuticals stock logo

Abattis Bioceuticals OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

4Front Ventures stock logo

4Front Ventures OTCMKTS:FFNTF

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.